Search
Categories


Posts Tagged ‘approval’

Lannett Receives FDA Approval For Phentermine Hydrochloride Capsules USP 30 Mg

Thursday, July 22nd, 2010

Lannett Company, Inc. (NYSE AMEX: LCI) announced that it has received approval from the U.S. Food and Drug Administration (FDA) of its Abbreviated New Drug Application ( ANDA) for Phentermine Hydrochloride Blue/White Seed Capsules USP, 30 mg, the generic equivalent of Sandoz, Inc.’s Reference Listed Drug (RLD) Phentermine Hydrochloride Capsules USP, 30 mg. According to Wolters Kluwer, U.S. sales of Phentermine Hydrochloride Capsules USP, 30 mg (more…)

Pill intended to boost female sex drive falls short of goals, FDA says as it mulls approval

Friday, June 18th, 2010

WASHINGTON (AP) — A pink pi ll designed to boost sex drive in women — the latest attempt by the drug industry to find a female equivalent to Viagra — fell short in two studies, federal health regulators said Wednesday.

The Food and… (Source: OrlandoSentinel: Medical Research)

MedWorm Message: Register for MedMatcha, MedWorm’s medical advertising network, and receive $5 free advertising.

Lannett Receives FDA Approval For Phentermine

Saturday, May 29th, 2010

Lannett Company, Inc. (Amex:LCI) announced it has received approval from the U.S. Food and Drug Administration (FDA) for the company’s supplemental Abbreviated New Drug Application (ANDA) of Phentermine Hydrochloride Capsules 30 mg. The company expects to commence marketing this product immediately. Phentermine Hydrochloride (HCl) is indicated for the short-term management of obesity. [cl ick link for full article] (Source: Obesity / Weight Loss (more…)

Application for approval of Qnexa (phentermine and topiramate) for obesity submitted to the FDA

Wednesday, May 26th, 2010

Source: BioS pace
Area: News
According to BioSpace, a New Drug Application (NDA) has been submitted to the US FDA seeking approval of Qnexa® (controlled-release oral formulation of low dose phentermine and topiramate) for the treatment of obesity, including weight loss and maintenance of weight loss, in patients who are obese or overweight with co-morbidities such as hypertension, type 2 diabetes, dyslipidaemia or central adiposity.  (more…)

Caraco Pharmaceutical Laboratories, Ltd. Announces FDA Approval to Market Generic Version of Adipex-P(R)

Wednesday, May 26th, 2010

DETROIT, Aug. 22 (HSMN NewsFeed) — Caraco Pharmaceutical Laboratories, Ltd., (Amex: CPD ) announce d today that the US Food and Drug Administration (FDA) has granted final approval for the Company’s Abbreviated New Drug Application (ANDA) for Phentermine… Biopharmaceuticals, Generics, FDACaraco Pharmaceutical, Phentermine, Adipex-P, TEVA Pharmaceutical (Source: HSMN NewsFeed)

Barr Receives Approval For Generic XANAX XR(R) Tablets

Friday, May 21st, 2010

Barr Laboratories, Inc., a subsidiary of Barr Pharmaceuticals, Inc. (NYSE: BRL), today announced that it received final approval from the U.S. Food and Drug Administration (FDA) for its application to manu facture and market ageneric version of Pfizer Inc.’s XANAX XR(R) (Alprazolam Extended-Release)Tablets, 0.5 mg, 1 mg, 2 mg and 3 mg. The Company intends to launch itsproduct immediately. [click link for full article] (Source: Psychology / Psychiatry (more…)

Barr Receives Approval For Generic XANAX XR(R) Tablets

Wednesday, May 19th, 2010

Barr Laboratories, Inc., a subsidiary of Barr Pharmaceuticals, Inc. (NYSE: BRL), today announced that it received final approval from the U.S. Food and Drug Administration (FDA) for its application to manufacture and market ageneric version of Pfizer Inc.’s XANAX XR(R) (Alprazolam Extended-Release)Tablets, 0.5 mg, 1 mg, 2 mg and 3 mg. The Company intends to launch itsproduct immediately. [click link for full article] (Source: Health N ews from (more…)

IMPAX Receives Final FDA Approval for Generic Xanax(R) XR Extended Release Tablets

Wednesday, May 19th, 2010

Global Pharmaceuticals Division to Launch

HAYWARD, Calif.–(HSMN NewsFeed)–IMPAX Laboratories, Inc. (OTC:IPXL ) today announced that the U.S. Food and Drug Administration (FDA) has granted final approval of the Company’s Abbreviated New Drug Applicatio… Biopharmaceuticals, Generics, FDAIMPAX Laboratories, Xanax, Alprazolam, Xanax XR, Pharmaci a (Source: HSMN NewsFeed)

Actavis Receives Approval of Alprazolam ODT in the U.S.

Thursday, May 6th, 2010

Actavis Group, the international generic pharmaceuticals company, today announced that it has received approval from the U.S. Food & Drug Administration to market Alprazolam orally disintegrating tablets. Distribution of the product will commence immediately. (Source: Pharmaceutical Online News)

MedWorm Message: Get the v ery latest Swine Flu news via the MedWorm Swine Flu RSS news feed – updated hourly from thousands of authoritative (more…)

Lannett Receives FDA Approval For Phentermine

Thursday, March 4th, 2010

Lannett Company, Inc. (Amex:LCI) announced it has received approval from the U.S. Food and Drug Administration (FDA) for the company’s supplemental Abbreviated New Drug Application (ANDA) of Phentermine Hydrochloride Capsules 30 mg. The company expects to commence marketing th is product immediately. Phentermine Hydrochloride (HCl) is indicated for the short-term management of obesity. [click link for full article] (Source: Obesity / Weight Loss (more…)

Page 1 of 212